Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation

  1. Daniel R. Ambruso*,,,
  2. Cindy Knall§,
  3. Amy N. Abell§,
  4. Julie Panepinto,
  5. Arlet Kurkchubasche,
  6. Gail Thurman*,
  7. Carolina Gonzalez-Aller*,
  8. Andrew Hiester*,
  9. Martin deBoer,
  10. Ronald J. Harbeck**,
  11. Ryan Oyer§,
  12. Gary L. Johnson§, and
  13. Dirk Roos
  1. *Bonfils Blood Center, Denver, CO 80220; Department of Pediatrics, and §Pharmacology, University of Colorado Health Sciences Center, Denver, CO 80262; Departments of Pediatric Hematology/Oncology and Surgery, Rhode Island Hospital, Providence, RI 02903; Central Laboratory of the Netherlands Blood Transfusion Service and Laboratory of Experimental and Clinical Immunology, Academic Medical Center, Amsterdam, The Netherlands; and **Clinical Labs, National Jewish Medical and Research Center, Denver, CO 80206
  1. Communicated by Henry R. Bourne, University of California, San Francisco, CA (received for review December 22, 1999)

Abstract

A 5-week-old male infant presented with severe bacterial infections and poor wound healing, suggesting a neutrophil defect. Neutrophils from this patient exhibited decreased chemotaxis, polarization, azurophilic granule secretion, and superoxide anion (O2 ) production but had normal expression and up-regulation of CD11b. Rac2, which constitutes >96% of the Rac in neutrophils, is a member of the Rho family of GTPases that regulates the actin cytoskeleton and O2 production. Western blot analysis of lysates from patient neutrophils demonstrated decreased levels of Rac2 protein. Addition of recombinant Rac to extracts of the patient neutrophils reconstituted O2 production in an in vitro assay system. Molecular analysis identified a point mutation in one allele of the Rac2 gene resulting in the substitution of Asp57 by an Asn (Rac2D57N). Asp57 is invariant in all defined GTP-binding proteins. Rac2D57N binds GDP but not GTP and inhibits oxidase activation and O2 production in vitro. These data represent the description of an inhibitory mutation in a member of the Rho family of GTPases associated with a human immunodeficiency syndrome.

Footnotes

  • To whom reprint requests should be addressed at: Bonfils Blood Center, 717 Yosemite Circle, Denver, CO 80230. E-mail: daniel.ambruso{at}UCHSC.edu.

  • Article published online before print: Proc. Natl. Acad. Sci. USA, 10.1073/pnas.080074897.

  • Article and publication date are at www.pnas.org/cgi/doi/10.1073/pnas.080074897

  • Abbreviations:
    PMA,
    phorbol myristate acetate;
    PAF,
    platelet-activating factor;
    fMLP,
    formyl-methionyl, leucyl-phenylalanine;
    LAD,
    ;
    MPO,
    myeloperoxidase;
    SOD,
    superoxide dismutase;
    GTP[γS],
    guanosine 5′-[γ-thio]triphosphate;
    GST,
    glutathione S-transferase;
    EBV,
    Epstein–Barr virus
« Previous | Next Article »Table of Contents